5 completed, 1 terminated, 1 withdrawn. 6 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 4, Terminated 1, Withdrawn 1 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow ibutamoren mesylate: new trials by email Literature Review of ibutamoren mesylate trials Research Report on ibutamoren mesylate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease LUM-201 - NAFLD, Nonalcoholic Fatty Liver | Phase 2 | Completed | Massachusetts General Hospital | 12 | 2022-08-10 | 2026-01-06 |
| Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Stage 4/5 Subjects MK-0677, Placebo - Chronic Kidney Disease, Kidney Disease | Phase 2 | Withdrawn | University of Virginia | 2009-03-01 | 2018-05-14 | |
| Growth Hormone Secretagogue MK-0677 Effect on IGF-1 Levels in ESRD Patients MK-0677, Placebo - Chronic Kidney Disease, End Stage Renal Disease | Not applicable | Completed | University of Virginia | 49 | 2006-08-01 | 2017-02-20 |
| Treatment of Sarcopenia in Post-Hip Fracture Patients (0677-032) MK0677 - Hip Fracture | Phase 2 | Terminated | Merck Sharp & Dohme LLC | 83 | 2005-09-01 | 2016-01-20 |
| Efficacy and Safety of an Oral Growth Hormone Drug in the Treatment of Fibromyalgia Ibutamoren Mesylate (MK-0677) - Fibromyalgia | Phase 2 | Completed | Bennett, Robert, M.D. | 64 | 2005-07-01 | 2012-08-06 |
| Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED) MK0677 - Alzheimer's Disease | Phase 2 | Completed | Merck Sharp & Dohme LLC | 512 | 2003-10-01 | 2015-07-24 |
| Effects of an Oral GH Secretagogue (MK-677) on Body Composition and Functional Ability of Older Adults Orally active growth hormone secretagogue (MK-677) - Aging | Phase 1 / Phase 2 | Completed | University of Virginia | 72 | 1998-07-01 | 2007-05-16 |
Renal Insufficiency, Chronic (2) · Alzheimer Disease (1) · Fibromyalgia (1) · Hip Fractures (1) · Kidney Diseases (1) · Kidney Failure, Chronic (1) · Non-alcoholic Fatty Liver Disease (1) · Sarcopenia (1)
University of Virginia (3) · Merck Sharp & Dohme LLC (2) · Bennett, Robert, M.D. (1) · Massachusetts General Hospital (1)
United States (5) · Germany (1) · Norway (1) · Spain (1) · Sweden (1) · United Kingdom (1)
Laura E. Dichtel, MD, MHS (1) · Michael O. Thorner, MBBS, DSc, (1) · Robert Bennett, MD (1) · Warren K Bolton, MD (1) · Warren K. Bolton, MD (1)